Back to search

Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling

Data up to Jan 2025

Published1993
Citations73
References27

Total Citations Per Year

Abstract

References (27)

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

Regression Models and Life-Tables

1972 • 27,145 citations

Monoclonal Antibody to 5-Bromo- and 5-Iododeoxyuridine: A New Reagent for Detection of DNA Replication

1982 • 2,648 citations

— Tumors of the Central Nervous System

2013 • 1,787 citations

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas

1978 • 1,663 citations

Autoantibody to a Nuclear Antigen in Proliferating Cells

1978 • 881 citations

An analysis of dose-effect relationship in the radiotherapy of malignant gliomas

1979 • 850 citations

A method to measure the duration of DNA syntheses and the potential doubling time from a single sample

1985 • 599 citations

A Classification of the Tumors of the Glioma Group on a Histogenetic Basis with a Correlated Study of Prognosis.

1926 • 595 citations

A Classification of the Tumors of the Glioma Group on a Histogenetic Basis with a Correlated Study of Prognosis.

1927 • 294 citations

Immunocytochemical demonstration of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in human brain tumor tissues

1985 • 178 citations

Relationship between labeling indices of KI-67 and brdurd in human malignant tumors

1988 • 177 citations

Prognostic implications of the bromodeoxyuridine labeling index of human gliomas

1989 • 168 citations

A commentary on the biology and growth kinetics of low-grade and high-grade gliomas

1984 • 159 citations

Prognostic implications of the proliferative potential of low-grade astrocytomas

1988 • 155 citations

Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry.

1988 • 128 citations

S‐phase fraction of human brain tumors in situ measured by uptake of bromodeoxyuridine

1986 • 123 citations

Flow-cytometric DNA analysis and immunohistochemical measurement of Ki-67 and BUdR labeling indices in human brain tumors

1989 • 114 citations

Prediction of tumor doubling time in recurrent meningiomas

1986 • 110 citations

Effects of fixation time and enzymatic digestion on immunohistochemical demonstration of bromodeoxyuridine in formalin-fixed, paraffin-embedded tissue.

1988 • 108 citations

An immunohistological method for estimating cell growth fractions in rapid histopathological diagnosis during surgery

1985 • 74 citations

Flow cytometric estimation of cell cycle parameters using a monoclonal antibody to bromodeoxyuridine

1986 • 67 citations

Detection of proliferative cells in dysplasia, carcinoma in situ, and invasive carcinoma of the uterine cervix by monoclonal antibody against DNA polymerase α

1988 • 45 citations

Comparison of bromodeoxyuridine labeling indices obtained from tissue sections and flow cytometry of brain tumors

1988 • 35 citations

Demonstration of proliferating cell nuclear antigen (PCNA/Cyclin) in glioma cells.

1987 • 23 citations

Cell cycle phase dependent emergence of thymidylate synthase studied by monoclonal antibody (M‐TS‐4)

1989 • 9 citations

Cited By (0)

Loading...
Prognostic significance of the proliferative potential of intracranial gliomas measured… (1993) – International Journal of Cancer | Metascience Observatory Explorer